The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study

Authors

Jonathan I. Silverberg (ORCID: https://orcid.org/0000-0003-3686-7805)
Eric L. Simpson (ORCID: https://orcid.org/0000-0003-0853-0252)
Amy S. Paller (ORCID: https://orcid.org/0000-0001-6187-6549)
Michael J. Cork (ORCID: https://orcid.org/0000-0003-4428-2428)
Peter D. Arkwright (ORCID: https://orcid.org/0000-0002-7411-5375)
Ashish Bansal (ORCID: https://orcid.org/0000-0002-7371-6486)
Randy Prescilla (ORCID: https://orcid.org/0000-0001-7672-5460)
Ainara Rodríguez Marco
Zhen Chen (ORCID: https://orcid.org/0000-0003-1603-4638)
Zhixiao Wang (ORCID: https://orcid.org/0000-0003-1928-3103)

Institutions

Oregon Health & Science University (US)
Regeneron (United States) (US)
George Washington University (US)
University of Manchester (GB)
Sanofi (Spain) (ES)
Sanofi (United States) (US)

Publication Details

Journal: Journal of the American Academy of Dermatology
Published: 2024-09-28
DOI: https://doi.org/10.1016/j.jaad.2024.09.039
Citations: 6
Primary Topic: Dermatology and Skin Diseases
Type: article
Field-Weighted Citation Impact: 3.21

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study

Jonathan I. Silverberg, Eric L. Simpson, Amy S. Paller, Michael J. Cork et al.

Sep 28, 2024

6 citations

Journal of the American Academy of Dermatology

Dermatology and Skin Diseases

3.21

article

The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study

Jonathan I. Silverberg, Eric L. Simpson, Amy S. Paller, Michael J. Cork, Peter D. Arkwright, Ashish Bansal, Randy Prescilla, Ainara Rodríguez Marco, Zhen Chen, Zhixiao Wang

September 28, 2024article en

6 citations

Abstract

No abstract available for this paper.

Journal of the American Academy of DermatologyVol. 92(1)

Oregon Health & Science University (US), Regeneron (United States) (US), George Washington University (US), University of Manchester (GB), Sanofi (Spain) (ES), Sanofi (United States) (US)

Openalex Percentile: Top 8%

Dermatology and Skin Diseases

3.21

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study — Jonathan I. Silverberg, Eric L. Simpson, et al. · Journal of the American Academy of Dermatology (2024) | TGRS Research Map | TGRS